Home > Balance Sheet > NATCO PHARMA

NATCO PHARMA
Sundry Debtors

    Back to Balance Sheet
NATCO PHARMA is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Sundry Debtors History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Sundry Debtors ₹1,189 Cr₹856 Cr₹621 Cr₹413 Cr₹551 Cr

What is the latest Sundry Debtors ratio of NATCO PHARMA ?

The latest Sundry Debtors ratio of NATCO PHARMA is ₹1,189 Cr based on Mar2024 Consolidated results.
Year Sundry Debtors
Mar2024₹1,189 Cr
Mar2023₹856 Cr
Mar2022₹621 Cr
Mar2021₹413 Cr
Mar2020₹551 Cr

How is Sundry Debtors of NATCO PHARMA Trending?

Years Sundry Debtors % Change
Mar2024 ₹1,189 Cr
38.87
Mar2023 ₹856 Cr
37.95
Mar2022 ₹621 Cr
50.30
Mar2021 ₹413 Cr
-25.10
Mar2020 ₹551 Cr -

Compare Sundry Debtors of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹21,044.3 Cr -9.8% -15.3% 32% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹416,692.0 Cr -5.3% -7.8% 24.1% Stock Analytics
DIVIS LABORATORIES ₹149,215.0 Cr -3.9% -7.9% 51% Stock Analytics
CIPLA ₹115,000.0 Cr -1.9% -6.9% 3.6% Stock Analytics
DR REDDYS LABORATORIES ₹98,616.4 Cr -8.3% -14.9% 0.8% Stock Analytics
ZYDUS LIFESCIENCES ₹93,841.4 Cr -5.7% -4% 23.6% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-9.8%

-15.3%

32%

SENSEX

0.2%

-2.2%

7.7%


You may also like the below Video Courses